Buy Genmab - ADR Stock | GMAB Stock Price & Latest News | Public
GMAB

Genmab - ADR

$0.00 (0.00%)Today

    About GMAB

    Genmab A/S operates as an international biotechnology company. The firm develops human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline include daratumumab, marketed as DARZALEX for the treatment of certain indications of multip...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.82
    0.55
    0.27
    0
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    $0.11

    Actual EPS
    Q4 2020

    Stats

    Market Cap$25,25B
    Volume9,72k
    Price-to-Earnings Ratio29.85
    Dividend Rate
    Dividend Yield
    1 Year High$39.81
    1 Year Low$16.24
    Open$38.06
    High$38.43
    Low$38.01

    Buy any stock with any amount of money.

    Download the App
    Download the app